Javascript must be enabled to continue!
Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
View through CrossRef
Abstract
Background
Transcatheter tricuspid valve intervention (TTVI) is increasingly utilized for symptomatic severe tricuspid regurgitation (TR), particularly in high-risk surgical patients. The Society of Thoracic Surgeons Tricuspid Regurgitation (STS-TR) score, that was developed for prediction of 30-day mortality after tricuspid valve surgery. The purpose of the current study is to evaluate the performance of the STS-TR score in patients who underwent TTVI.
Methods
A six-center international cohort of 457 patients who underwent TTVI for symptomatic severe or greater TR between 2019-2024 were assessed using the STS-TR score. TTVI included tricuspid edge-to-edge repair (T-TEER) (n=243), tricuspid valve replacement (TTVR) (n=131), and transcatheter tricuspid annuloplasty (TTA) (n=83). The STS-TR 30-day all-cause mortality score was calculated for each patient and compared to observed mortality. The performance of the STS-TR score was assessed using calibration plots, the Hosmer-Lemeshow (H-L) test, and C-statistic. Subgroup analyses were performed based on TTVI procedure type.
Results
Mean age was 78.6 ± 8.7 years, and 54.7% were female. The mean predicted 30-day all-cause STS-TR mortality was 8.16% ± 7.2%, while the observed mortality was 2.63% (p < 0.001). Subgroup analyses revealed similar calibration patterns, Figure 1. Calibration plots demonstrated overestimation across all procedure types. The C-statistic for the STS-TR score was 0.68 (95% CI: 0.54 - 0.82) (Figure 2), indicating suboptimal discrimination
Conclusions
The STS-TR score for isolated TR significantly overestimates TTVI 30-day mortality across all procedure types, including transcatheter repair (T-TEER and TTA) and replacement (TTVR), and demonstrates suboptimal discrimination. This may be related to lower risk of TTVI procedures compared to surgery or disparate cohorts. Prospective dedicated TTVI-specific risk prediction models for transcatheter repair and replacement procedures are needed.
Oxford University Press (OUP)
Title: Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
Description:
Abstract
Background
Transcatheter tricuspid valve intervention (TTVI) is increasingly utilized for symptomatic severe tricuspid regurgitation (TR), particularly in high-risk surgical patients.
The Society of Thoracic Surgeons Tricuspid Regurgitation (STS-TR) score, that was developed for prediction of 30-day mortality after tricuspid valve surgery.
The purpose of the current study is to evaluate the performance of the STS-TR score in patients who underwent TTVI.
Methods
A six-center international cohort of 457 patients who underwent TTVI for symptomatic severe or greater TR between 2019-2024 were assessed using the STS-TR score.
TTVI included tricuspid edge-to-edge repair (T-TEER) (n=243), tricuspid valve replacement (TTVR) (n=131), and transcatheter tricuspid annuloplasty (TTA) (n=83).
The STS-TR 30-day all-cause mortality score was calculated for each patient and compared to observed mortality.
The performance of the STS-TR score was assessed using calibration plots, the Hosmer-Lemeshow (H-L) test, and C-statistic.
Subgroup analyses were performed based on TTVI procedure type.
Results
Mean age was 78.
6 ± 8.
7 years, and 54.
7% were female.
The mean predicted 30-day all-cause STS-TR mortality was 8.
16% ± 7.
2%, while the observed mortality was 2.
63% (p < 0.
001).
Subgroup analyses revealed similar calibration patterns, Figure 1.
Calibration plots demonstrated overestimation across all procedure types.
The C-statistic for the STS-TR score was 0.
68 (95% CI: 0.
54 - 0.
82) (Figure 2), indicating suboptimal discrimination
Conclusions
The STS-TR score for isolated TR significantly overestimates TTVI 30-day mortality across all procedure types, including transcatheter repair (T-TEER and TTA) and replacement (TTVR), and demonstrates suboptimal discrimination.
This may be related to lower risk of TTVI procedures compared to surgery or disparate cohorts.
Prospective dedicated TTVI-specific risk prediction models for transcatheter repair and replacement procedures are needed.
.
Related Results
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Abstract
Background
Redo isolated tricuspid valve surgery has high in-hospital mortality and morbidity and is a challenging procedure. We report a s...
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
Abstract
Tricuspid valve regurgitation is a major clinical issue that continues to attract interest from interventional cardiologists and medical device designers du...
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Abstract
Background
In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective ...
An Acoustically Controlled Down-Hole Safety Valve (SCSSSV)
An Acoustically Controlled Down-Hole Safety Valve (SCSSSV)
American Institute of Mining, Metallurgical, and Petroleum Engineers, Inc.
Abstract
A surface-controlled subsurface safety valve...
Incidence, predictors and outcomes of Valve-in-valve (ViV) Transcatheter aortic valve replacement (TAVR): a systematic review and meta-analysis
Incidence, predictors and outcomes of Valve-in-valve (ViV) Transcatheter aortic valve replacement (TAVR): a systematic review and meta-analysis
Abstract
Background
Surgical aortic valve replacement has been the treatment of choice for patients with aortic valve disease be...
Abstract 10999: Long-Term Outcomes of Atrioventricular Valve Regurgitation and Repair in Patients With Single Ventricle Physiology
Abstract 10999: Long-Term Outcomes of Atrioventricular Valve Regurgitation and Repair in Patients With Single Ventricle Physiology
Introduction:
In single ventricle patients, AV valve regurgitation increases the risk of adverse outcomes, and staged palliation with concomitant AV valve intervention ...
Emerging insights into tricuspid valve disorders: epidemiology, clinical entities, innovations, and future perspectives
Emerging insights into tricuspid valve disorders: epidemiology, clinical entities, innovations, and future perspectives
Tricuspid valve disorders (TVDs) have historically been underrecognized by clinicians. However, recent years have seen increasing awareness of their clinical impact. This mini-revi...
P1720 Hammock mitral valve, a challenging echocardiographic diagnosis
P1720 Hammock mitral valve, a challenging echocardiographic diagnosis
Abstract
We report a 43 year-old female with a past TTE echocardiography of rheumatic valve disease performed in her district h...

